Bristol-Myers Squibb has formed an R&D partnership with GentiBio, aimed at developing regulatory T cel (Treg) therapies for inflammatory bowel disease (IBD). The deal includes an undisclosed upfront ...
Exscientia has signed up another big pharma partner for its artificial intelligence (AI) based drug discovery platform, this time attracting a $50 million upfront buy-in from Bristol-Myers Squibb. BMS ...
AP Inter 1st Year Model Papers 2026 are an important study resource for students preparing for the upcoming AP Intermediate public examinations. The examination authority has released the latest model ...
Find your added subjects in My Bitesize. The purpose and nature of businesses - AQA Entrepreneurs may choose to set up a business for a number of reasons and there are a number of business sectors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results